GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹260 Cr | ₹249 Cr | ₹247 Cr | ₹255 Cr | ₹262 Cr |
What is the latest Long Term Provisions ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹260 Cr |
| Mar2025 | ₹249 Cr |
| Mar2024 | ₹247 Cr |
| Mar2023 | ₹255 Cr |
| Mar2022 | ₹262 Cr |
How is Long Term Provisions of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹260 Cr | 4.40 | |
| Mar2025 | ₹249 Cr | 0.66 | |
| Mar2024 | ₹247 Cr | -2.88 | |
| Mar2023 | ₹255 Cr | -2.83 | |
| Mar2022 | ₹262 Cr | - | |
Compare Long Term Provisions of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹50,118.7 Cr | -3.1% | 14.7% | 4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -3.1% |
14.7% |
4.7% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses